Sarepta Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference
January 02 2018 - 8:30AM
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage
biopharmaceutical company focused on the discovery and development
of precision genetic medicines to treat rare neuromuscular
diseases, today announced that management will present at the 36th
Annual J.P. Morgan Healthcare Conference in San Francisco, CA on
Monday, January 8th at 1:30 p.m. ET / 10:30 a.m. PT. Following the
presentation there will be a Q&A session starting at 2:00 p.m.
ET / 11:00 a.m. PT.
The presentation and Q&A session will be
webcast live under the investor relations section of Sarepta’s
website at www.sarepta.com and will be archived there following the
presentation and Q&A session for 90 days. Please connect to
Sarepta's website several minutes prior to the start of the
broadcast to ensure adequate time for any software download that
may be necessary.
About Sarepta
Therapeutics
Sarepta Therapeutics is a commercial-stage
biopharmaceutical company focused on the discovery and development
of precision genetic medicines to treat rare neuromuscular
diseases. The Company is primarily focused on rapidly advancing the
development of its potentially disease-modifying Duchenne muscular
dystrophy (DMD) drug candidates. For more information, please visit
www.sarepta.com.
Internet Posting of
Information
We routinely post information that may be
important to investors in the 'For Investors' section of our
website at www.sarepta.com. We encourage investors and
potential investors to consult our website regularly for important
information about us.
Source: Sarepta Therapeutics, Inc.
Media and Investors: Sarepta Therapeutics, Inc. Ian Estepan,
617-274-4052 iestepan@sarepta.com or W2O Group Brian Reid,
212-257-6725 breid@w2ogroup.com
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Apr 2023 to Apr 2024